Call for Applications: DSMB Training on Safety Monitoring in Clinical Trials (Africa CDC) 2026
The Africa Centres for Disease Control and Prevention (Africa CDC) is an autonomous institution of the African Union that supports Member States in planning, preparing for, and responding to health threats and disease outbreaks across the continent. Africa CDC’s work is guided by the principles of credibility, ownership, delegated authority, timely dissemination of information, transparency, accountability, and value addition.
Within Africa CDC, the Science and Innovation Division is responsible for promoting effective safety monitoring in clinical trials to uphold ethical research standards and protect participant well-being.
Adverse events may occur during the administration of investigational products, making strong oversight essential for risk assessment and timely interventions. The Data and Safety Monitoring Board (DSMB) plays a critical role in reviewing clinical trial safety data, safeguarding participants, and ensuring the integrity of study results.
To strengthen DSMB expertise across Africa, Africa CDC—in collaboration with the Safety Platform for Emergency Vaccines (SPEAC)—is offering a structured training course in data safety monitoring.
Also Apply:Â Call for Applications: PTDF Overseas Postgraduate Scholarship Programme 2026 | UK, Germany, France & Malaysia
Eligibility
The training is open to professionals working in:
- Vaccine safety surveillance organisations
- Clinical trial hubs
- National Regulatory Authorities (NRAs) / National Pharmacovigilance (PV) centres
- Ethics committees
Applicants should have a background in clinical trials or vaccine pharmacovigilance.
Trainers and Facilitators
The course will be delivered by a team of experienced trainers from SPEAC, a CEPI-funded initiative designed to enhance safety monitoring for CEPI-funded trials across multiple platforms and priority pathogens.
Also Apply: Federal Ministry of Education Launches ₦50m Student-Led Venture Capital Grant Programme (S-VCG)
Certification Requirements
To receive a Certificate of Completion in Safety Monitoring in Clinical Trials, participants must:
- Score 70% or higher in all quizzes
- Actively participate in all live sessions (maximum of two absences permitted)
- Score 70% or higher on the final exam (two attempts allowed)
Registration and Participant Selection
- Course Start Date: February 12, 2026
- Registration Deadline: January 31, 2026
- Application Deadline: January 31, 2026
Required Application Details
Applicants must provide:
- Full name
- Country of residence
- Current position
- Vaccine, DSMB, and clinical trial-related experience
- Curriculum Vitae (CV)
- Contact information (phone number and email)
Also Apply:Â Call for Applications: SMEDAN GrowHer Accelerator Program (2nd Cohort) for Women Entrepreneurs 2026
Method of Application
- All applications must be submitted via the online application form.
- Incomplete applications will not be considered.
Applicants must also submit:
- A support letter from the current employer
- Two letters of recommendation from reputable professional referees
- A personal statement (maximum 500 words) demonstrating commitment to medicine safety in Africa. The statement should highlight the applicant’s technical qualifications, professional experience and achievements, and their vision for strengthening medicine safety and regulatory systems across the continent.
